1 | UGT1A10, UGT1A9
|
| How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
|
| Itäaho K, Laakkonen L, Finel M.
|
| Drug Metab Dispos 38(4):687-96. Epub 2010 Jan 20.PMID: 20089735 2010
|
2 | UGT1A10, UGT1A8, UGT1A9
|
| Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.
|
| Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP.
|
| J Biol Chem 285(9):5993-6002. Epub 2010 Jan 6.PMID: 20053997 2010
|
3 | UGT1A10
|
| Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10.
|
| Itäaho K, Court MH, Uutela P, Kostiainen R, Radominska-Pandya A, Finel M.
|
| Drug Metab Dispos 37(4):768-75. Epub 2008 Dec 30.PMID: 19116261 2009
|
4 | UGT1A10
|
| Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene.
|
| Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A.
|
| Steroids 73(1):139-47. Epub 2007 Sep 29.PMID: 17981312 2008
|
5 | UGT1A10, UGT1A8
|
| Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.
|
| Li X, Bratton S, Radominska-Pandya A.
|
| Drug Metab Pharmacokinet 22(3):152-61.PMID: 17603215 2007
|
6 | UGT1A10
|
| Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk.
|
| Elahi A, Bendaly J, Zheng Z, Muscat JE, Richie JP Jr, Schantz SP, Lazarus P.
|
| Cancer 98(4):872-80. 2003
|
7 | UGT1A8, UGT1A9, UGT1A10
|
| Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.
|
| Gregory PA, Gardner-Stephen DA, Lewinsky RH, Duncliffe KN, Mackenzie PI.
|
| J Biol Chem 278(38):36107-14. Epub 2003 Jul 7. 2003
|
8 | UGT1A, UGT1A10, UGT1A11P, UGT1A12P, UGT1A2P, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A8, UGT1A9
|
| The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.
|
| Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW.
|
| Pharmacogenetics 7(4):255-69. Review. 1997
|